Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
2003 4
2005 2
2006 1
2007 1
2010 1
2011 1
2012 2
2013 3
2014 4
2015 3
2016 2
2018 4
2019 2
2020 3
2021 2
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
New and Evolving Techniques for the Characterization of Peptide Therapeutics.
D'Addio SM, Bothe JR, Neri C, Walsh PL, Zhang J, Pierson E, Mao Y, Gindy M, Leone A, Templeton AC. D'Addio SM, et al. Among authors: templeton ac. J Pharm Sci. 2016 Oct;105(10):2989-3006. doi: 10.1016/j.xphs.2016.06.011. Epub 2016 Aug 4. J Pharm Sci. 2016. PMID: 27499338 Review.
The Journey to AAPS 2020: a Reflection from Strategic Planning to PharmSci 360.
Polli JW, McCurdy CR, Wurster DE, DeSilva BS, Bak A, Bendayan R, Meibohm B, Templeton AC, Weiser W; AAPS Leadership. Polli JW, et al. Among authors: templeton ac. AAPS PharmSciTech. 2018 Nov;19(8):3325-3327. doi: 10.1208/s12249-018-1200-3. Epub 2018 Nov 3. AAPS PharmSciTech. 2018. PMID: 30390237 No abstract available.
Strategies for bringing drug delivery tools into discovery.
Kwong E, Higgins J, Templeton AC. Kwong E, et al. Among authors: templeton ac. Int J Pharm. 2011 Jun 30;412(1-2):1-7. doi: 10.1016/j.ijpharm.2011.03.024. Epub 2011 Mar 21. Int J Pharm. 2011. PMID: 21421040 Review.
Flexibility in Drug Product Development: A Perspective.
Kapoor Y, Meyer RF, Ferguson HM, Skomski D, Daublain P, Troup GM, Dalton C, Ramasamy M, Templeton AC. Kapoor Y, et al. Among authors: templeton ac. Mol Pharm. 2021 Jul 5;18(7):2455-2469. doi: 10.1021/acs.molpharmaceut.1c00210. Epub 2021 Jun 24. Mol Pharm. 2021. PMID: 34165309
Processing Impact on Performance of Solid Dispersions.
Zhang D, Lee YC, Shabani Z, Frankenfeld Lamm C, Zhu W, Li Y, Templeton A. Zhang D, et al. Among authors: templeton a. Pharmaceutics. 2018 Aug 30;10(3):142. doi: 10.3390/pharmaceutics10030142. Pharmaceutics. 2018. PMID: 30200245 Free PMC article.
Implications of In-Use Photostability: Proposed Guidance for Photostability Testing and Labeling to Support the Administration of Photosensitive Pharmaceutical Products, Part 3. Oral Drug Products.
Allain L, Baertschi SW, Clapham D, Foti C, Lantaff WM, Reed RA, Templeton AC, Tønnesen HH. Allain L, et al. Among authors: templeton ac. J Pharm Sci. 2016 May;105(5):1586-1594. doi: 10.1016/j.xphs.2016.02.035. Epub 2016 Apr 5. J Pharm Sci. 2016. PMID: 27056630 Review.
Implications of In-Use Photostability: Proposed Guidance for Photostability Testing and Labeling to Support the Administration of Photosensitive Pharmaceutical Products, Part 2: Topical Drug Product.
Baertschi SW, Clapham D, Foti C, Kleinman MH, Kristensen S, Reed RA, Templeton AC, Tønnesen HH. Baertschi SW, et al. Among authors: templeton ac. J Pharm Sci. 2015 Sep;104(9):2688-701. doi: 10.1002/jps.24396. Epub 2015 Feb 24. J Pharm Sci. 2015. PMID: 25711373 Review.
36 results